EuroLyser
EUROLyser Diagnostica GmbH develops point-of-care diagnostic instruments (CUBE, CUBE-S, CUBE-VET) and single-use immunoturbidimetric and enzymatic test kits, serving physician practices, hospital ERs, and veterinary clinics across more than 30 countries through a global distributor network as an affiliate of Mars, Incorporated.
- Company typePrivate
- Founded2003
- HeadquartersSalzburg, Austria
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What EuroLyser does
EUROLyser Diagnostica GmbH (EuroLyser), headquartered in Salzburg, Austria, and operating as an affiliate of Mars, Incorporated, develops and manufactures point-of-care diagnostic instruments and single-use test kits for two segments: human medical diagnostics and veterinary diagnostics. The core instrument line consists of the CUBE and CUBE-S analyzers (for human use) and the CUBE-VET and EUROLyser solo analyzers (for veterinary use), all built around a factory-calibrated, maintenance-free architecture with an Android-based tablet interface, RFID-enabled reagent kits that carry pre-set calibration curves and lot/expiry data, and bidirectional ASTM/HL7 connectivity to practice management software, HIS, and LIMS systems. The underlying assay technology relies on homogeneous immunoturbidimetric and enzymatic measurement methods, with a reagent menu covering inflammation (CRP, hsCRP, SAA, cCRP, Fibrinogen), kidney function (Cystatin C, SDMA, NH3), metabolic and endocrine markers (HbA1c, BHB, Fructosamine, Cortisol, T4), liver function (GLDH), cardiac markers (Troponin I), coagulation (D-Dimer), anemia (Ferritin), reproductive health (canine, bovine and equine Progesterone), drug monitoring (Phenobarbital), and screening (iFOB, Lipoprotein(a)), with most tests delivering results in under ten minutes.
The company monetizes through a razor-and-blade model: upfront sales of instruments followed by recurring revenue from proprietary single-use test kits, which are sold in 6- and 16-test pack sizes alongside control kits. Go-to-market is primarily indirect, executed through a network of authorized distributors covering more than 30 countries across Europe (Germany, Denmark, Italy, Netherlands, Poland, Romania, Switzerland, Austria and others), Asia (Japan via Sysmex, South Korea, Taiwan), the Middle East (Israel, Iraq), Africa (Morocco, Tanzania), and the Americas (USA, Canada, Caribbean). EUROLyser supplements this with a direct sales portal for the Austrian market, an eHealth/telemedicine-optimized CUBE-S variant, and software tools including ConneXport for PC data transfer and the EVOS cloud platform for veterinary data synchronization. The company holds ISO 13485:2016 and ISO 27001:2022 certifications, which underpin its ability to sell CE-marked in-vitro diagnostic devices into regulated healthcare markets, and it serves primary customer segments of physician practices and hospital ERs (human diagnostics) and companion-animal and production-animal veterinary clinics (veterinary diagnostics).
EuroLyser firmographics
Firmographics- Name
- EuroLyser
- Legal name
- EUROLyser Diagnostica GmbH
- Website
- https://eurolyser.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- EUROLyser Diagnostica GmbH develops point-of-care diagnostic instruments (CUBE, CUBE-S, CUBE-VET) and single-use immunoturbidimetric and enzymatic test kits, serving physician practices, hospital ERs, and veterinary clinics across more than 30 countries through a global distributor network as an affiliate of Mars, Incorporated.
- Ownership category
- akta.pro rank
EuroLyser industry classification
Industry- Product category
- Point-of-Care Diagnostics
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy) (HLAMAFAI)
- akta.pro secondary industry
- Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI)
Keywords
Where EuroLyser is headquartered
LocationHeadquarters
- HQ city
- Salzburg
- HQ country
- Austria
- HQ region
- Europe
Offices1 record
Markets served
EuroLyser business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Point-of-care diagnostic instruments: Sale of CUBE, CUBE-S, and CUBE-VET instruments along with solo veterinary analyzer for point-of-care testing in medical practices and veterinary clinics.
- Single-use test kits and reagents: Recurring revenue from sale of test kits (CRP, Cystatin C, SDMA, cortisol, etc.) that are consumed with each test. Test kits come in various pack sizes (6 or 16 tests) and include control kits.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
EuroLyser product offering
Product offeringCore offering
EuroLyser Diagnostica GmbH designs, manufactures, and distributes point-of-care diagnostic instruments and single-use test kits for both human medical diagnostics and veterinary diagnostics. The product portfolio centers on the CUBE-series analyzers (CUBE-S for human use, CUBE-VET for veterinary use) with Android-based tablet interfaces, the EUROLyser solo veterinary analyzer, and the EUROLyser smart medical analyzer, paired with a broad menu of immunoturbidimetric and enzymatic reagent kits covering inflammation, kidney function, cardiac markers, diabetes, reproductive health, and metabolic monitoring.
Product overview
EUROLyser Diagnostica GmbH is a point-of-care diagnostics company offering a portfolio of instruments and single-use test kits for both medical (human) and veterinary diagnostics. The core product lines include the CUBE-S and CUBE-VET analyzers (with Android-based tablet interfaces), the EUROLyser solo (veterinary predecessor), and the EUROLyser smart (medical). The company provides an extensive menu of compatible test reagents covering inflammation (CRP, SAA, Fibrinogen), metabolic disorders (Cortisol, T4, Fructosamine, Lactate), kidney function (SDMA, Cystatin C, NH3), liver function (GLDH), cardiac markers (Troponin I), diabetes (HbA1c, BHB), reproduction (Progesterone variants), coagulation (D-Dimer), and drug monitoring (Phenobarbital). Software tools include ConneXport for PC data transfer and EVOS for cloud-based result accessibility. All products are designed for point-of-care use with rapid turnaround times (typically under 10 minutes) and maintenance-free operation.
Differentiator
Problem solved
Functional benefit
Brands
- CUBE: Point-of-care medical diagnostic instrument series with Android-based interface and tablet PC for human diagnostics.
- CUBE-S
- CUBE-VET
- EUROLyser solo
- ConneXport
- EVOS
Products and services
- CUBE-S
Quantifiable outcome
- Test results available in minutes rather than days
- +1 more outcomes
Companies that use EuroLyser
Customer profileSegments2 records
Ideal customer profiles2 records
EuroLyser technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature5 records
EuroLyser partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sysmex CorporationcoreSysmex Corporation, a global market leader in hematology, and EUROLyser Diagnostica expanded their successful cooperation to include sales of EUROLyser's point-of-care systems measuring CRP (C-reactive protein) in the Japanese market. The Japanese market is globally acknowledged as 'high end' in terms of laboratory systems. Sysmex is responsible for distributing EUROLyser products in Japan, leveraging their established presence and reputation in the Japanese healthcare market.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
EuroLyser competitors and assessment
Company assessmentBroad incumbents
- IDEXX Laboratories: IDEXX is the global leader in companion-animal diagnostics (Catalyst, ProCyte, SediVue) and competes head-to-head with EUROLyser's veterinary menu across in-clinic analyzers and consumables.
- Abbott (i-STAT): Abbott's i-STAT is the dominant handheld point-of-care analyzer for human diagnostics (chemistry, cardiac, coagulation). EUROLyser competes in the same POC analyzers + single-use-cartridge model for physicians and ERs.
- Roche Diagnostics (cobas): Roche's cobas Liat and broader POC portfolio compete in physician-office and hospital rapid testing — same clinical use cases (CRP, HbA1c, D-Dimer) as EUROLyser CUBE/CUBE-S.
- QuidelOrtho: QuidelOrtho's Triage and Sofia platforms serve rapid POC immunoassay testing in clinics and hospitals — broadly overlapping EUROLyser's cardiology/inflammation tests (Troponin, CRP, D-Dimer).
Emerging players
- Bühlmann Laboratories: Swiss specialty diagnostics company with a strong fecal/calprotectin and veterinary assay menu. Comparable as a focused specialty-IVD reagent maker overlapping with EUROLyser on select veterinary and inflammatory tests.
- Trinity Biotech: Trinity Biotech develops POC clinical chemistry and immunology tests (e.g., HIV, hemoglobin A1c) sold via distributor networks globally — same razor/blade consumable model and customer profile as EUROLyser.
Direct peers
- EKF Diagnostics: EKF builds point-of-care analyzers and reagents (QuikRead, Hemo Control) for clinical and veterinary markets, with a similar razor/blade consumable model and customer base to EUROLyser.
- Nova Biomedical: Nova manufactures StatStrip and other POC blood-gas/chemistry analyzers and consumables; competes with EUROLyser in physician-office and hospital POC chemistry segments.
- Zoetis (Vetscan): Zoetis's Vetscan line is a direct competitor to CUBE-VET and EUROLyser solo in veterinary point-of-care diagnostics (chemistry, hematology, immunoassays), sold through veterinary channels globally.
- Heska (acquired by Mars/Antech): Heska, now part of Mars-owned Antech, sells in-clinic veterinary analyzers and consumables. Direct competitor to CUBE-VET, and notably a Mars sister company — making it both ally and rival.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
EuroLyser social profiles
Digital presenceEuroLyser compliance and trust
Trust signalCompliance2 records
EuroLyser financial estimates
Financial estimateRevenue estimate
Valuation estimate
EuroLyser leadership team
Management profileNumber of profiles
Profiles3 records
EuroLyser funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EuroLyser M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EuroLyser
What does EuroLyser do?
EuroLyser Diagnostica GmbH designs, manufactures, and distributes point-of-care diagnostic instruments and single-use test kits for both human medical diagnostics and veterinary diagnostics. The product portfolio centers on the CUBE-series analyzers (CUBE-S for human use, CUBE-VET for veterinary use) with Android-based tablet interfaces, the EUROLyser solo veterinary analyzer, and the EUROLyser smart medical analyzer, paired with a broad menu of immunoturbidimetric and enzymatic reagent kits covering inflammation, kidney function, cardiac markers, diabetes, reproductive health, and metabolic monitoring.
Is EuroLyser a public or private company?
EuroLyser is a private company. It is classified as corporate owned and is currently operating.
When was EuroLyser founded?
EuroLyser was founded in 2003. It employs 1 to 10 people.
Where is EuroLyser based?
EuroLyser is headquartered in Salzburg, Austria, in the Europe region.
How does EuroLyser make money?
Two revenue lines are on record. Point-of-care diagnostic instruments are the primary driver. The others are single-use test kits and reagents.
Who are EuroLyser's main competitors?
Broad incumbents on record are IDEXX Laboratories, Abbott (i-STAT), Roche Diagnostics (cobas) and QuidelOrtho. Emerging players are Bühlmann Laboratories and Trinity Biotech. Direct peers are EKF Diagnostics, Nova Biomedical, Zoetis (Vetscan) and Heska (acquired by Mars/Antech).
Does EuroLyser have an API?
No public API is recorded for EuroLyser.
What industry is EuroLyser in?
EuroLyser's product category is Point-of-Care Diagnostics. Its primary akta.pro industry code is HLAMAFAI, Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy), with a secondary code of HLAMADAI, Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers). Its NAICS code is 334516 and its SIC code is 2835.